Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: NorthSea Therapeutics B.V.
February 12, 2026
NorthSea Therapeutics B.V.
Orphan Drug Designation
treatment of intestinal failure associated liver disease
Disease Area:
Rare Disease
Source
Scroll to Top